Top 50 Life Science VC (Venture Capital) Funds in Spain in July 2025
A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Spain. We rank investors based on the number of investments they made in Life science companies from Spain. We update this investor list every month.Top 50 Life Science VC (Venture Capital) Funds in Spain in July 2025
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Seed, Grant
- Spain, United States, France
Portfolio highlights
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
- Ideeea Therapeutics — Ideeea Therapeutics is a biotechnology start-up focused on advanced therapies (ATMPs).
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more
Investment focus
- Software, Information Technology, Enterprise Software
- Funding Round, Seed, Series A
- Spain, United States, Mexico
Portfolio highlights
- MLCode — Accelerated by massive AI/ML adoption, Data is to become the most critical resource for Enterprises. MLCode vision is to protect that Data. MLCode: Data Security Automation.
- wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
- Inspiration-Q — Inspiration-Q focuses on developing and commercializing software solutions inspired by quantum computing for financial applications.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Equity Crowdfunding, Seed, Funding Round
- Spain, United States, United Kingdom
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- OxyPrem — OxyPrem is a Swiss manufacturer of next-generation medical devices for oxygen-related brain monitoring of preterm infants in real time, using harmless, non-invasive near-infrared light. Our sensors continuously measure local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
- MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
- Biotechnology, Medical Device, Health Care
- Series A, Seed, Series B
- Spain, France, Belgium
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Debt Financing, Pre-Seed
- Spain, United States, France
Portfolio highlights
- Mygocu — Mygocu is a platform for selling, organizing, and managing excursions and large-scale events.
- Supercubo — Supercubo is a Spanish startup based in Seville, founded with the goal of promoting healthy lifestyle habits by facilitating the creation of outdoor functional training centers through a scalable, low-risk, and cost-effective solution.Our project aims to both ease access for entrepreneurs and foster the growth of our community.The company wasfounded in December 2023 (starting operations in March 2024), and to date, the proof-of-concept for our three business lines has already been implemented and validated: • Own gyms • Franchisees • Third-party sales
- Modular DS — Modular DS enables WordPress professionals and businesses to save time managing their websites.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Seed, Funding Round, Series A
- Spain, France, Belgium
Portfolio highlights
- Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Pre-Seed, Series A
- Canada, United States, United Kingdom
Portfolio highlights
- Xatoms — At Xatoms, we clean water with Quantum Chemistry and AI, revolutionizing water purification for communities worldwide. Our innovative approach rapidly identifies new, sustainable materials to remove harmful pollutants and pathogens. We aim to alleviate the burden on women and girls in underrepresented communities, transforming the global landscape of water accessibility and empowering a more equitable world. Xatoms is at the forefront of combining scientific innovation with social change.
- Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success.
- Investment and growth
- Specialized products and branches
- Collaborative innovation
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Funding Round, Pre-Seed
- Spain, Mexico, United States
Portfolio highlights
- Kloutit — Gestiona los chargebacks potenciando las defensas con IA
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Spain, United States, Switzerland
Portfolio highlights
- ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more
Investment focus
- Software, Biotechnology, E-Commerce
- Seed, Funding Round, Series A
- Spain, United States, United Kingdom
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Scalestack — Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline.
- iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Pre-Seed, Seed, Series A
- Spain, Portugal, Poland
Portfolio highlights
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- KomboAI — Increase your sales conversion rate and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. 7-Days Free Trial See Kombo in Action No credit card required Over 600+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right
- Aino — Get site analysis in minutes instead of weeks by just asking questions to AI. No coding or GIS skils needed.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Pre-Seed, Series A
- United States, Germany, United Kingdom
Portfolio highlights
- Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
- Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
- Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series B, Seed, Series A
- United Kingdom, United States, Spain
Portfolio highlights
- Inephany — Inephany - We build systems to train AI agents specialised in optimising Neural Networks, such as LLMs and other Generative AI.
- Safe Intelligence — Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
- iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Seed, Funding Round, Series A
- Spain, United States, United Kingdom
Portfolio highlights
- Orbidi — Orbidi is a digital marketing agency that provides SEO, website building, and Google Maps integration services for businesses.
- Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
- The Channel Store — The Channel Store is a company specializing in the creation, distribution, and monetization of various types of channels, particularly in the FAST (Free Ad-Supported Streaming TV) and AVOD (Ad-Supported Video on Demand) sectors. It operates as a B2B service provider that manages content negotiations, integration, and monetization for its partners,enabling broadcasters, content owners, telcos, and streaming services to access and distribute a wide range of live and on-demand content globally.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more
Investment focus
- Software, Biotechnology, Pharmaceutical
- Seed, Funding Round, Pre-Seed
- Spain, Portugal
Portfolio highlights
- Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
- Appentra — Ensure correctness, modernization, security, and optimization for your Fortran, C, and C++ code with a powerful and efficient solution.
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).
Show more
Investment focus
- Medical Device, Financial Services, Medical
- Seed, Funding Round, Series A
- United States, United Kingdom, Spain
Portfolio highlights
- Scout AI — Scout AI is building the robotic foundation model for defense.
- Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity.
Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way.
We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view.
We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money.
We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community.
We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more
Investment focus
- Biotechnology, Life Science, Medical
- Seed, Funding Round
- Spain
Portfolio highlights
- Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
- Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Series A, Funding Round, Seed
- Spain, United States
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
We back founders who see the future differently.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Series A, Seed, Series B
- United Kingdom, United States, Germany
Portfolio highlights
- Acin — Acin delivers at speed by combining unique industry data, AI and high touch expertise. The trusted partner, built by the industry, for the industry
- Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
- Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more
Investment focus
- Life Science, Biotechnology
- Seed
- Spain
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more
Investment focus
- Genetics, Life Science, Biotechnology
- Series A
- Spain
Portfolio highlights
- Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Pre-Seed
- United Kingdom, Germany, Austria
Portfolio highlights
- Mercanis — Source services smarter and drive automation along your source-to-settle process. Discover how Mercanis enables you to collaborate with best-in-class suppliers across your departments.
- ORUS — ORUS specializes in high-resolution hyperspectral spatial data and associated analytical services.
- Tibo Energy — To make sure you operate within the limits of your contract we control your network. We avoid congestion in your energy network.
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more
Investment focus
- Solar, Energy, Medical
- Series A, Seed, Series B
- Canada, Spain
Portfolio highlights
- SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more
Investment focus
- Biotechnology, Wellness, Biopharma
- Series A, Funding Round
- Spain
Portfolio highlights
- Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
- ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more
Investment focus
- Medical, Biopharma, Life Science
- Funding Round
- Spain
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Debt Financing
- Spain, United States, Mexico
Portfolio highlights
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Supporting impact innovators to bring their breakthrough technologies to the market, for a healthier, safer and more sustainable world.
Show more
Investment focus
- Biopharma, Health Care, Life Science
- Seed, Funding Round
- Spain
Portfolio highlights
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
- NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more
Investment focus
- Internet, Health Care, Information Technology
- Seed, Angel, Funding Round
- Spain, Norway, Switzerland
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- Belgium, United States, Spain
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- SafeHeal — SafeHeal is a clinical stage medical device manufacturer focusing on the development of anastomosis protection devices, including Colovac, for colorectal surgery.
- Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
- One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more
Investment focus
- Biotechnology, Software, Medical
- Funding Round, Seed, Series A
- Spain, Germany, United States
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
This Declaration by leaders of city and regional governments, NGOs, and other stakeholders calls on national governments to promote healthy and sustainable diets through the drafting and implementation of Action Plans for Plant-Based Foods.
Show more
Investment focus
- Food and Beverage, Food Processing, Nutrition
- Seed, Pre-Seed, Series A
- Germany, China, Spain
Portfolio highlights
- Poseidona — We provide sustainable protein ingredients from seaweed side-streams and invasive algae so manufacturers can develop the tastiest food products.
- Quazy Foods — Quazy Foods unleashes the power of microalgae for healthy, sustainable, and competitive functional ingredients.
- Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
UCB Ventures is a €150 million strategic corporate venture fund
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Belgium, Spain
Portfolio highlights
- ViaNautis — Precision Solutions
- Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
- Switch Therapeutics — Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Debt Financing, Funding Round, Seed
- Spain, United States, Mexico
Portfolio highlights
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
- Harmonix — Harmonix is a software development company that uses AI for CRM to communicate with customers to send email, calls, and SMS.
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series A, Seed, Series B
- France, Switzerland, Spain
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Clave Capital is an independent asset management company that specializes in investment strategy.
Show more
Investment focus
- Biotechnology, Health Diagnostics, Health Care
- Seed, Funding Round
- Spain
Portfolio highlights
- MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
- Nanological — Ultra-fast Identification of Bacteria for Sepsis Diagnosis - Multiparametric characterization of mass, size and optical absorption through optical and mechanical measurements to achieve real-time direct pathogen identification.
- ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Seed, Series B
- Switzerland, United States, France
Portfolio highlights
- Risklick — Risklick is develops a first-of-the-kind data-driven tool to allow end-users to identify similar Clinical trials(CTs) and assess risks in early steps of the protocol design. CTs are used to determine the efficacy and safety of an experimental treatment; however, up to 90% of them fail in the early stage of protocol design and the nature andcomplexity of CTs make risk assessment difficult and time-consuming.
- StratifAI — Advancing precision oncology with AI-driven biomarkers that analyze histology images & clinical data.
- MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more
Investment focus
- Software, FinTech, Financial Services
- Series A, Series B, Series C
- United States, Brazil, Canada
Portfolio highlights
- Tines — Tines is an enterprise automation platform designed to help security and ops teams automate manual workloads. With 1,000+ template options for common security actions, Tines is power and simplicity through direct integration with your existing tools. The company was founded in 2018 and is headquartered in Dublin.
- Base Power — Base provides a battery-powered home energy service so you can enjoy power without interruption and save money. Now available in select regions of Texas.
- SuperOps.ai — SuperOps is a future-ready, unified PSA-RMM platform for modern MSPs. Break away from the bane of LegacyOps tools and unlock your full potential.
All-in-one solution for fundraising, managing and trading equity. Explore promising tech startups and flexible funding opportunities with SeedBlink.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Series A
- Romania, United States, United Kingdom
Portfolio highlights
- Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
- Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
- dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.
We back bold and purpose-driven founders.
Show more
Investment focus
- Software, Insurance, InsurTech
- Series A, Seed, Funding Round
- Spain, United States, United Kingdom
Portfolio highlights
- LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
- Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Series B, Series C
- United States, India, Canada
Portfolio highlights
- NG.CASH — NG.CASH is a digital app designed to help Generation Z become financially independent. It allows users to manage their own money with solutions such as PIX (Brazil’s “instant-payment” method), prepaid credit card, allowance management and a virtual card, in addition to features that let users customise the app’s design and a marketplace withdiscounts on Gen Z’s most desired brands. Structured as a financial hub, NG.CASH aims to accompany its clients throughout their lives and increase financial literacy in the region.
- Wispr Flow — Wispr AI is a developer of the next-generation of neural interfaces to provide seamless interface with immersive technology. The company is working with the leading neuroscientist, hardware engineers, machine learning researchers, and product engineers to bring frontier technology to the mass consumer market.
- Spyglass Pharma — Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications.
Alantra is an international financial services firm with over 500 professionals across EMEA, the Americas, and Asia.
Show more
Investment focus
- Financial Services, Manufacturing, Information Technology
- Private Equity, Debt Financing, Series B
- Spain, France, Sweden
Portfolio highlights
- enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
- SunRoof — Roof of the future
- Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more
Investment focus
- Energy, Financial Services, Renewable Energy
- Debt Financing, Post-IPO Debt, Seed
- United Kingdom, Spain, United States
Portfolio highlights
- Klar — Klar is a FinTech challenger bank that provides deposit and credit services for Mexican customers.Using the Klar card rewards users with cash of up to 4% cashback for each purchase, not points without confusing conversions or expiration dates. Clients can also send and receive payments and collections money instantly to Klar accounts and otherbanks. The Klar card is linked to an app where users can see all their movements in real-time.Stefan Moller, Daniel Autrique, Jeronimo Riefkohl, and Gianluigi Davassi established the company in Mexico City, Distrito Federal in 2018.
- Tritax Big Box — Tritax Big Box is the only Real Estate Investment Trust dedicated to investing in very large logistics facilities in the UK. they own, manage and develop some of the UK’s most sought-after Big Boxes. rBig Boxes are strategically important to tenants as they offer efficiency savings and are increasingly fulfilling e-commerce retail sales.tenantsinclude some of the biggest names in retail, logistics, consumer products and automotive.they aim to provide a secure and growing income for Shareholders, together with capital appreciation. their ambition is to be the UK’s pre-eminent owner of Big Boxes.
- Clearway Energy Group — We're a leading independent clean power developer and operator with over 350 clean energy projects across America.
Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.
Show more
Investment focus
- Medical, Biopharma, Life Science
- Funding Round
- Spain
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
stemar capital private equity philippe costeletos
Show more
Investment focus
- Genetics, Life Science, Biotechnology
- Series A
- Spain
Portfolio highlights
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series C, Series A, Series B
- United States, Canada, Spain
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
- CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Funding Round, Seed
- Spain, Mexico
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Series A, Pre-Seed
- Germany, Israel, United States
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more
Investment focus
- Food and Beverage, Biotechnology, Food Processing
- Seed, Equity Crowdfunding, Pre-Seed
- United Kingdom, Sweden, Brazil
Portfolio highlights
- Super Vegan — Loja de chocolates veganos
- SHICKEN Foods — Plant-based chicken manufacturer
- The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Publishing
Video Games
Music
Art
Wellness
Franchise
Mobile
Local
Digital Media
Legal
Android
eSports
Enterprise Software
Sports
Manufacturing
Email
Medical
Social Network
Social Media
Internet
Construction
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Travel
Fitness
Recruiting
Crowdfunding
Social
Medical Device
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Belarus
Chile
Belgium
Armenia
Hong Kong
Finland
Ghana
Georgia
Saudi Arabia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Sri Lanka
Estonia
Costa Rica
Hungary
Greece
Barbados
China
Croatia
Belize
Bahrain
Czech Republic
Algeria
Africa
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Oceania
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Japan
Liechtenstein
Philippines
Vietnam
Italy
Israel
Poland
Panama
Dominican Republic
Senegal
Nigeria
Iraq
Sierra Leone
Azerbaijan
Tunisia
Bahamas
Iceland
Togo
Serbia
Namibia
United Arab Emirates
Turkey
Jamaica
San Marino
Thailand
Honduras
Uzbekistan
Bolivia
Taiwan
Isle of Man
Luxembourg
Sweden
Tanzania
Albania
Pakistan
Slovenia
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Grenada
Jordan
Uganda
Bangladesh
Venezuela
Argentina
Romania
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Latvia
Cyprus
Oman
Austria
Switzerland
Colombia
Seychelles
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Spain by industry
Clean Energy
Restaurants
Crowdfunding
Venture Capital
Financial Services
Transportation
Big Data
Finance
Food and Beverage
Video Games
Organic Food
Wine And Spirits
Medical
Wellness
Medical Device
Proptech
Internet
Social Media
Digital Media
Manufacturing
Platforms
Android
Mobile
Blockchain
Music
Local
Software
Legal
Construction
eSports
Enterprise Software
Sports
Fitness
Hospitality
Automotive
Travel
InsurTech
Recruiting
Mobile Advertising
FinTech
Consumer
Health Care
Biotech
Energy
Climate
EdTech
Sustainability
Impact
Marketplace
Artificial intelligence
Hardware
Community
Gaming
Retail
Social
Beauty
Web3
B2B
Life Science
Publishing
Photography
Oil and Gas
Renewable Energy
Payments
Mobile Apps
Sporting Goods
Art
Education
Social Impact
Cryptocurrency
SaaS
Biotechnology
Social Network
Real Estate
Fashion
Media (entertainment)
Infrastructure
Agriculture (agtech)
Machine Learning
CleanTech
Enterprise